1. Introduction {#s0005}
===============

In 2015, cancer caused over eight million deaths, making it the second leading cause of death in the world, nearly one-sixth deaths caused by cancer according to the report of the World Health Organization [@b0005], [@b0010]. The impact of cancer on economy is significant and growing [@b0015], [@b0020], [@b0025], and the cancer is common in late manifestations and inaccessible diagnosis and treatment [@b0030]. If detected early, cancer can respond to effective treatments, leading to lower morbidity, less treatment spending and larger chances of survival [@b0035]. Thus, an effective early diagnosis and treatment can improve the cure rate of many cancers and alleviate the burden of cancer patients [@b0040].

It is important to develop more effective early diagnosis strategies for cancer, and biomarkers are urgently needed to diagnose various types of cancers, assess the severity of diseases, and discover the corresponding therapeutics [@b0045], [@b0050], [@b0055], [@b0060], [@b0065], [@b0070], [@b0075]. A biomarker can be a protein, a polypeptide or a metabolite whose levels change with the stage of cancer, as well as the messenger RNA or other kinds of nucleic acids [@b0080], [@b0085], [@b0090], [@b0095]. It is well known that there is much less understanding of the pathogenesis of cancer at the proteomic level than gene mutations level [@b0100], [@b0105]. Since proteome is a functional translation of genome and a rich source of biomarkers, huge amounts of time and money are needed for proteomics to develop biomarker [@b0110]. Gene is merely a "formulation" of the cell, and the protein encoded by the gene is ultimately a functional participant in normal and cancer physiology [@b0115]. Thus, while the genetic background contributes in part to the susceptibility and development of cancer [@b0120], cancer can now be considered as a proteome disease and has more links to the post-transcriptional steps [@b0125], [@b0130]. In terms of patient prognosis, there is an urgent need for protein markers distinguishing cancer patients from normal individuals. In addition, biomarkers used in cancer surveillance may affect the development of new therapy [@b0135]. Protein biomarkers obtained from biological samples can not only provide starting point for finding links between disease and biological pathway, but also play an important role in advancing cancer medical research through the early diagnosis of cancer and prognosis of treatment interventions [@b0140]. An ideal biomarker should be with the following characteristics: (1) good consistency and (2) high reproducibility on same phenotyping biological samples, and (3) good classification performance at distinguishing cases from controls across studies [@b0145], [@b0150], [@b0155].

Recently, a well-rounded analysis of human genome, transcriptome, proteome and metabolome has made significant advance, making a significant contribution to the discovery of tumor biomarkers [@b0160]. Proteomics can provide the qualitative and quantitative information on proteins based on a multitude of complex biological samples [@b0165], [@b0170], It is also a powerful technique for identifying potential proteomic biomarkers, facilitating the discovery of anticancer drug targets and providing new sight into mechanism underlying complicated cancers [@b0175], [@b0180], [@b0185], [@b0085]. The workflow of cancer biomarker discovery based on quantitative proteomics is illustrated in [Fig. 1](#f0005){ref-type="fig"}. In the proteomics study, it is critical for assessing the performance of feature selection methods using the external validations strategy [@b0190]. The external validation implies the presence of a test dataset of samples that has not been employed for constructing the model, and could be considered the suitable strategy for avoiding overfitting problem [@b0190].Fig. 1The workflow of cancer biomarker discovery in quantitative proteomics study.

Due to the sparsity of features in a big proteomic data, feature selection methods are applied to identify significant proteins/peptides (or features) between distinct groups, which is a crucial step for cancer classification, diagnosis and prognosis in the comparative proteomics study [@b0190], [@b0195], [@b0200], [@b0205], [@b0210]. Currently, diverse feature selections have been developed and applied to the analyzed proteomic data in various cancer-associated studies [@b0205]. However, due to the lack of robustness of feature selection methods, the robustness and consistency of the biomarker sets discovered in most cases is ambiguous [@b0215], [@b0220].

This review describes recent computational advances made in the field of cancer proteomics from biomarker candidates' identification perspectives. A variety of popular feature selection techniques applied to cancer proteomic data are overviewed with critical assessments of both challenges and potentials. The main aim of this review is to make practitioners aware of the benefits and the necessity of applying feature selection techniques.

2. Considerations concerning study design {#s0010}
=========================================

Tumor heterogeneity, design of study, sample size sand selection of the reference sample should be considered for discovering tumor biomarker in proteomic study [@b0225], [@b0230], [@b0235]. For example, the use of normal/healthy controls as a reference group also needs to be made cautiously [@b0235]. The inter-individual heterogeneity among tumors could affect proteins biomarker expression [@b0240] and could result in inappropriate "normal controls" samples employed for tumor biomarker discovery [@b0240]. Moreover, a relatively large numbers of samples employed could provide the biomarker validation in study design [@b0245].

3. Feature selection for tumor marker identification {#s0015}
====================================================

Feature selection techniques have become quite popular as well as required in tumor marker identification [@b0250], [@b0255], [@b0260], [@b0265]. The application of feature selection techniques not only facilitates the identification of optimal differential oncological protein features [@b0270], [@b0275], [@b0280], but also improves cancer risk stratification and prediction [@b0285], [@b0290]. The available feature selection techniques can be organized into three categories based on their theories of screening variables and classifying distinct groups: filter methods, wrapper methods and embedded approaches. Moreover, one of the major problems in proteomics dataset is the treating of missing values. The imputation methods widely applied in proteomics data included the background imputation, Bayesian principal component imputation, censored imputation, k-nearest neighbor imputation, local least squares imputation and singular value decomposition [@b0295].

As shown in [Fig. 2](#f0010){ref-type="fig"}, a common taxonomy of feature selection methods in different categories is provided, and the corresponding advantages and disadvantages of these methods are discussed with examples of the most influential techniques. Due to the various types of feature selection techniques available for tumor marker identification ([Table 1](#t0005){ref-type="table"}), it is a great challenge to identify the optimal approach for analyzing any tumor marker-related study. The extensive application of each feature selection methods in current proteomic study together with popular sample classification methods are shown in [Fig. 3](#f0015){ref-type="fig"}. These common feature selection techniques currently available for tumor marker identification are overviewed as follow.Fig. 2Classification of available feature selection algorithms in cancer proteomic study.Table 1Different feature selection methods for identifying the markers in proteomics research.MethodsExtensive application of each feature selection methods in current proteomic research**Filter-based feature selection methods**1Fold changeUsed to identify the protein markers for early screening detection and monitoring invasive breast cancer progression (*PLoS One*. 10:e0141876, 2015).2Entropy-based FiltersApplied to discover biomarkers from serum peptide profiling based on proteomic techniques (*Nat Protoc*. 2:588--602, 2007)3Analysis of varianceUsed to discover the biomarkers associated with the orthostatic hypotension based on the proteomic study (*Hypertension*. 71:465--72, 2018)4Chi-squareApplied to reveal a prognostic signature in oral cancer in combining discovery and targeted proteomics (*Nat Commun*. 9:3598, 2018)5Student\'s t-distributionPerformed to reveal the differential proteins between samples with and without primary dysmenorrhea (*F1000Res*. 7:59, 2018)6Significance Analysis of MicroarraysUsed to analyze significance between two biological samples in quantitative proteomic study (*BMC Bioinformatics*. 9:187, 2008)7Linear Models for Microarray DataApplied to find significantly affected proteins by cathepsin A via proteomic profiling (*J Proteome Res*. 15:3188--95, 2016)8Linear discriminant analysisUsed to find circulating lipids and coagulation cascade in septic shock progression based on proteomics data (*Sci Rep*. 8:6681, 2018)9Mann--Whitney--Wilcoxon testUsed to identify the candidate biomarkers of prostate cancer in proteomic study (*BMC Bioinformatics*. 16:169, 2015)10Correlation-based feature selectionUsed to screen the features for investigating the periplasmic expression of soluble proteins in Escherichia coli (*Sci Rep*. 6:21844, 2016)11Markov blanket filterUsed to detect proteomic biomarker in the recurrent ovarian cancer study from high-resolution mass spectrometry data (*IEEE Trans Inf Technol Biomed*. 13:195--206, 2009)12Partial Least Square Discriminant AnalysisApplied to select the discriminative proteins between the medullary sponge kidney and idiopathic calcium nephrolithiasis patients (*Int J Mol Sci*. 20:5517, 2019)13Orthogonal Partial Least Squares Discriminant AnalysisUsed to identify candidate biomarkers significantly discriminated cholangiocarcinoma from normal and periductal fibrosis patients (*PLoS One*. 14:e0221024, 2019)14Sparse Partial Least Squares Discriminant AnalysisApplied to discovery the protein biomarkers in hypertrophic cardiomyopathy based on proteomics profiling (*J Cardiovasc Transl Res*. 12:569--79, 2019)15Discriminant Analysis of Principal ComponentUsed to find conditions for the subsequent identification of biomarkers and stress proteins (*PLoS One*. 11:e0165504, 2016)  **Wrapper-based feature selection methods**1Sequential forward selectionUsed for protein mass spectrometry in the disease diagnosis and biomarker identification (*BMC Bioinformatics*. 6:68, 2005)2Sequential backward eliminationUsed to select k-spaced amino acid pairs to identify the pupylated proteins and pupylation sites based on proteomic data (*J Theor Biol*. 336:11--7, 2013)3Simulated annealingApplied to find a biomarker in prostate proteomic pattern based on prostate protein mass spectrometry data (*CIBCB*, 195--200, 2008)4Hill climbingsEmployed to tumor detection and discriminate tumor samples from nontumor ones in proteomic study (*Artif Intell Med.* 32:71--83, 2004)5Genetic algorithmUsed to identify proteomic patterns in serum that distinguish neoplastic from non-neoplastic disease (*Lancet*. 359:572--7, 2002)6Estimation of distribution algorithmApplied to identify the prognosis biomarker of ovarian cancer in metabolomic study (*Metabolomics*, 7:614--22 2011)  **Embedded feature selection methods**1Decision TreeUsed to automatically determine proteomic biomarkers and predictive models in the diagnosis of rheumatoid arthritis and inflammatory bowel diseases (*Bioinformatics*. 21:3138--45, 2005)2Support Vector MachineUsed to find proteins which differ between the breast cancer subtypes based on proteomic profiles (*Nat Commun*. 7:10259, 2016)3Weighted naïve BayesUsed to discover serum protein biomarkers for the diagnosis of active pulmonary tuberculosis based on proteomic profiling (*J Clin Microbiol*. 55:3057--71, 2017)4SVM Recursive Feature EliminationUsed to identify the biomarkers for predicting the early recurrence of ovarian cancer based on serum proteomic profiling (*Genome Inform*. 16:195--204, 2005)5Artificial Neural NetworksApplied to identify serum signatures for detecting hepatocellular carcinoma and its subtypes (*Clin Chem*. 49:752--60, 2003)6Random ForestUsed to identify the protein biomarkers in non-small cell lung cancer for early stage asymptomatic patients (*Cancer Genomics Proteomics*. 16:229--44, 2019)7RF Recursive Feature EliminationApplied to preliminarily screening the differential proteins for discovering biomarkers of hepatocellular carcinoma (*J Proteomics*. 225:103780, 2020)Fig. 3Feature selections applied in cancer proteomics and popular sample classification methods.

3.1. Filter methods for tumor marker identification from proteomic data {#s0020}
-----------------------------------------------------------------------

Filter methods involve in choosing the significantly differential features based on discriminating metric (e.g. *p*-value) that are relatively independent of classification. This metric well reflects the quality of each feature in terms of its discriminative power. The features would be remained when the metric values were within a specific criterion, and features beyond the thresholding condition would be eliminated. However, it should be noted that the feature selection based on p-value could be misleading when the difference is not based on regulation, but on the mere capacity of a cell to produce enough of the protein. Moreover, multicollinearity implies a strong correlation between features that affect the target vectors simultaneously. The multicollinearity problem could lead to instability of some feature selection method [@b0300]. The type of filter methods is relative of great simplicity compared to other wrapper and embedded methods. In particular, these filter methods can be organized into two categories based on the number of variables analyzed: (1) univariate and (2) multivariate methods. The former type refers to methods where only one variable is used for filter analysis, which includes Fold Change (FC), Entropy-based Filters, Analysis of Variance (ANOVA), Chi-square (χ^2^), Euclidian Distance, *T*-test, Information Gain (IG), Significance Analysis of Microarrays (SAM), Linear Models for Microarray Data (LIMMA) and Mann--Whitney--Wilcoxon test (MWW test). The later type refers to methods where at least two variables are considered for building modes, which include Correlation-based Feature Selection (CFS), Markov Blanket Filter (MBF), Linear Discriminant Analysis (LDA), Partial Least Square Discriminant Analysis (PLS-DA), Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA), Sparse Partial Least Squares Discriminant Analysis (sPLSDA), Discriminant Analysis of Principal Component (DAPC) and Relief. As reported previously, the univariate methods could be used to evaluate a single biomarker with respect to recurrence and outcome, and multivariate methods were employed to develop a prognostic classification panel for disease recurrence [@b0305]. The application of univariate and multivariate methods usually results in numerous significance features. Advantages of filter techniques are computationally simple and fast, and they are independent of the classification algorithm. A common disadvantage of filter methods is that they ignore the interaction with the classifier. Explanation and summary on each filter method are provided in [Table 2](#t0010){ref-type="table"}. And the detailed descriptions and the corresponding applications of cancer-regulated studies are as follow:Table 2Fifteen filter feature selection methods available and popular in cancer proteomic study.MethodsAbbr.Packages in R (*Function*)Brief DescriptionsReferenceFold changeFCmetabolomics (*FoldChange*)The FC is a popular and simple statistical method for the absolute value change between means of two groups. And it is often applied together with other parametric/non-parametric methods*Clin Cancer Res.* 18:3677--85, 2012Entropy-based FiltersEntropyFSelector (*entropy.based*)The Entropy filter method is similar to the Chi-square, which screens variables reraedless of possible interactions. And its performance depended on the characteristic s of studied data.*Comput Chem Eng*. 22:613--626, 1998.sAnalysis of varianceANOVAANOVA.TFNs (*fanova*)The ANOVA is a powerful statistical method of parametric/non-parametric and linear. And focus on analyzing the differences among multiple groups average values in a specific protein.*Br J Math Stat Psychol.* 68:23--42, 2015Chi-squareχ^2^stats (*chisq.test*)The χ^2^ is a popular statistical test of non-parametric, and difficult interpreting when the present of a large number of categories in the variables.*Am J Orthod Dentofacial Orthop.* 150:1066--1067, 2016Student\'s t-distribution*T*-teststats (*t.test*)The *T*-test is parametric method to judge whether the average of the two groups is statistically different.*Br J Educ Psychol.* 76:663--75, 2006Significance Analysis of MicroarraysSAMsamr (*sam*)The SAM is non-parametric and linear statistical technique. And rely on samples when carries out variable specific *t*-tests and ignore single variable*Proc Natl Acad Sci USA.* 98:5116--21, 2001Linear Models for Microarray DataLIMMAlimma (lmFit)The LIMMA is an advanced statistical method based on parametric and linear models. And analyze the reverse-phase protein array data*Nucleic Acids Res.* 43:e47, 2015Linear discriminant analysisLDAMASS (*lda*)The LDA is statistical algorithm based on the linear theory existing among different variables. And it is well suitable for study the small number of features.*Methods Mol Biol.* 1362:175--84, 2016Mann--Whitney--Wilcoxon testMWW teststats (*wilcox.test*)The MWW test is a nonparametric test of the null hypothesis. And it is well suitable when the assumptions of the *t* test or the data is ordered are not met.*J Wound Ostomy Continence Nurs.* 24:12, 1997Correlation-based feature selectionCFSFSelector (*cfs*)The CFS is a parametric and linear algorithm that have a heuristic search strategy. Its goal is to finalize a subset of the characteristics of these groups that are less correlated but highly.*Information Sciences.* 282:111--135, 2014Markov blanket filterMBFMXM (*mmmb*)The MBF is a based on discretized features feature selection statistical method, which can be applied for obtaining good classification performance with the small variables sets.*Med Phys.* 42:2421--30, 2015Partial Least Square Discriminant AnalysisPLS-DAropls (*opls*)\
caret (*plsda*)The PLS-DA is supervised multivariate statistical approach and belongs to type of linear two-class classifier. And is can maximize interval between predefined classes.*Chemometrics&Intelligent Laboratory Systems.* 58.2:109--130, 2001Orthogonal Partial Least Squares Discriminant AnalysisOPLS-DAropls (*opls*)The OPLS-DA is an advanced multivariate statistical method for one or more classes problems. And it is well suitable for classification of proteomic dataset when the variables often existed multi-collinear and noisy problems.*J. Chemometrics.* 20:341--351, 2006Sparse Partial Least Squares Discriminant AnalysissPLSDAropls (*opls*)\
mixOmics (*splsda*)The sPLS-DA is an advanced multivariate statistical algorithm for screening the variables and may miss out on variables between small sample sizes. The advantages of sPLS-DA are that variable selection and modeling are allowed in one step and can address multiclass problems.*BMC Bioinformatics.* 12:253, 2011Discriminant Analysis of Principal ComponentsDAPCadegenet (*dapc*)The DAPC is nonparametric and linear method. DAPC retains all property of DA without being dragged down by its restrictions.*BMC Genet.* 11:94, 2010

### 3.1.1. Univariate filter methods {#s0025}

Fold Change (FC) is to compare the absolute value change between means of two groups, and it is calculated as the ratio or log of the ratio of the mean metabolite levels between two groups. A threshold needs to be defined, if fold change value exceeds this threshold, the variable will be reported as significant. FC has been widely applied in multiple omics analysis to predict survival of patients with metastatic colorectal cancer [@b0310], and detect changes in the metabolomics profiles of men before and after androgen deprivation therapy for prostate cancer [@b0315].

Entropy-based Filters are filter-based feature ranking techniques which include three classes: Information Gain (IG), Gain Ratio (GR) and Symmetrical Uncertainty (SU). IG selects features based on contribution of information related to the class variable without considering feature interactions. GR is non-symmetrical measure that is introduced to compensate for the bias of the IG, and SU criterion compensates for the inherent bias of IG [@b0320]. Entropy-based Filters have been applied to identify the features related to glioma subtypes [@b0325] and discover biomarkers in Arabidopsis thaliana [@b0330].

A collection of statistical models and their associated estimation procedures was developed by Ronald Fisher called Analysis of Variance (ANOVA) [@b0335]. This method mainly focuses on analyzing the differences among different groups average or variance values in a specific protein [@b0340], [@b0345]. When comparing with multiple groups average values for statistical significance, it is more conservative than the traditional multiple two-sample *t*-tests method, and is therefore applicative for an extensive range of practical problems [@b0350]. The ANOVA has been applied to investigate pro-inflammatory cytokines and liver functional markers [@b0355] and explore the cellular resistance through quantitative proteomic analysis [@b0360].

When a hypothetical feature is actual independent of the class value, Chi-square (χ^2^) becomes a popular statistical test for weighting divergence distribution [@b0365]. It is known that the χ^2^ test is used to judge the independence of two events and its behavior is erratic for very small counts of cases [@b0370]. Using the χ^2^ statistic for feature selection is similar to importing a hypothesis testing about the distribution of classes [@b0375]. Chi-square has been applied to study the incidence of injury to parathyroid glands during surgery for papillary thyroid carcinoma [@b0380]. Main function of *t*-test is to judge whether the average of the two groups is statistically different [@b0385]. *T*-test is suitable for samples with a normal distribution [@b0390]. Commonly, the log transformation was needed for obtaining a more symmetric distribution prior to *t*-test analysis. Moreover, normalization is also a necessary step for proteomics analysis that aims to reduce systematic bias and make samples more comparable [@b0395], [@b0400], [@b0405], [@b0410], [@b0415], [@b0420]. As reported, the variance stabilization normalization (VSN) method has a built-in transformation and could perform well in the statistical analysis [@b0295], [@b0425]. However, *t*-test with multiple testing correction might not be appropriate when studied sample size is too small (less than 6) [@b0080]. The Multiple testing correction is a necessary step to manage the problem of false positive when performing multiple statistical tests in proteomics study [@b0190]. Popularly applied multiple testing correction methods included the Bonferroni correction, Holm correction and Benjamini-Hochberg correction. The *t*-test has been applied to distinguish prostate cancer from normal and benign conditions [@b0430].

In 2001, Virginia Tusher et al. developed a statistical technique called Significance Analysis of Microarrays (SAM) for judging whether statistical significance of gene expression changes exists [@b0435]. SAM can assign a grade to every protein according to the distinction in expression associative with the standard deviation and then give a permutation based false discovery rate (FDR) estimate [@b0435], [@b0440]. The advantage of this method is non-parametric statistics which uses repeated permutations of the data to judge whether the expression of protein is significant related to the response that is based on experimental conditions regardless of the distribution of individual proteins [@b0435]. SAM has been applied to identify specific serum proteomic features associated with hepatocellular carcinoma [@b0445].

A package called Linear Models for Microarray Data (LIMMA) focuses on differential expression gene analysis of file generated by simple or complex microarray experiments [@b0450]. Matching a linear model to the gene or protein expression data is a central idea of this method. The functions of input and normalization can be performed by LIMMA when two color microarray data need to be processed [@b0455]. Meanwhile, LIMMA can conjunct with the affyPLM or affy packages for Affymetrix data. It has been used in dopaminergic neurons function analysis for mouse and human fibroblasts [@b0460] and analysis of reverse-phase protein array data [@b0465]. LIMMA has been applied to investigate the influence of Cathepsin A on the cardiac proteome in a mouse model of cardiomyocyte-specific human Cathepsin A overexpression [@b0470].

A non-parametric alternative test of the null hypothesis called the Mann--Whitney--Wilcoxon test (MWW test) aims at comparing two mean values from the same sample and testing if two sample values are equally distributed [@b0475], [@b0480]. In general, the MWW test is used when the assumptions of the *t* test is not met [@b0485]. By comparing the distribution of results of two groups with outliers in the data, MWW test is widely used to observe the treatment effect [@b0490]. As reported, its performance would be dramatically improved with sample size increasing to a certain degree (more than 12) when compared with the other methods (e.g. PCDA) [@b0080], [@b0495]. The MWW test has been applied to identify candidate biomarkers of prostate cancer in proteomic study [@b0500]. This method is implemented based on the linear theory existing among features. The LDA has been applied to identify a set of physicochemical properties for facilitating the classification of metal-based colloids [@b0505].

### 3.1.2. Multivariate filter methods {#s0030}

Feature subsets among the features can be selected by Correlation-based Feature Selection (CFS) relying on the degree of redundancy [@b0510]. The evaluator\'s goal is to finalize a subset of the characteristics of these groups that are less correlated but highly related to the class [@b0515]. In particular, the subset evaluators search iteratively and add features using a numeric measure, for instance, conditional entropy [@b0520]. As a multivariate filter, the CFS considers the relationship between features not noticed by non-univariate filters [@b0515]. CFS is applied to select first-rate feature subset and is bonded with search methods, for example, bi-directional search, forward selection, genetic search and best-first search [@b0525]. CFS has been used in the subtype discovery of pediatric acute lymphoblastic leukemia by cancer microarray file [@b0530]. Based on discretized features, a feature selection method named Markov Blanket Filter (MBF) is raised [@b0535]. As a critical evaluation of MBF, contradictory and counterintuitive nature leads to undesirable properties on the small sample size applications which have function of classifying for microarray gene expression data [@b0540]. Linear Discriminant Analysis (LDA) is applied to identify differences or discriminant features among different samples groups and pattern classification [@b0545], which is quite suitable for studying the small number of features [@b0550].

Swedish statistician Herman O. A. Wold and his son Svante Wold proposed and developed Partial Least Square Discriminant Analysis (PLS-DA) [@b0555]. This method belongs to linear two-class classifier and maximize interval between predefined classes [@b0560]. The PLS-DA method will not produce the most accurate decision boundary once the sample sizes are unequal [@b0555]. This method is now usually applied by chemometricians who incorporate it into most pack-ages and is therefore cited in metabolomics papers [@b0565]. The PLS-DA combined other univariate methods has been applied to select the discriminative proteins between the medullary sponge kidney and idiopathic calcium nephrolithiasis patients [@b0570].

A supervised multiple regression analysis called Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) can be applied to identify the difference between different data sets of X and Y [@b0575]. The OPLS methods is an extended Partial Least Squares (PLS) method that combines an orthogonal signal correction filter to discriminate data changes from predictive quantitative response predictions that are useful from orthogonal predictions [@b0580]. This method is a powerful tool to analyze qualitative data structures and predicted results are similar to the results of standard PLS-DA [@b0585]. OPLS-DA has a primary advantage as for interpretation of the models due to its predictability [@b0590]. The OPLS-DA has been applied to identify candidate biomarkers significantly discriminated cholangiocarcinoma from normal and periductal fibrosis patients [@b0595]. Moreover, similar to the partial least squares discriminant analysis, the Sparse Partial Least Squares Discriminant Analysis (sPLS-DA) aims to achieve discrimination analysis based on PLS regression [@b0600]. When adding a Lasso penalization to select variables, sPLS-DA can select variable and reduce dimension simultaneously [@b0600]. sPLS-DA may tend to miss out on variables that only distinguish between small sample sizes, assuming effect size [@b0605]. The advantage of sPLS-DA is that variable selection and modeling are allowed in one step, and interpretability is improved through valuable graphical output [@b0610].

In 2010, Jombart and colleagues proposed Discriminant Analysis of Principal Components (DAPC) for inferring the number of genetically related individuals [@b0615]. DAPC and previously mentioned PLS-DA choose small-size feature sets precisely but miss many true positive features relevant to the spiked proteins [@b0080]. This multivariate statistical approach divides variance of the sample into between-group and within-group to maximize discrimination between groups. DAPC first converts the data using Principal Component Analysis (PCA) and then uses Discriminant Analysis (DA) to identify the cluster [@b0615]. As a new methodological approach, DAPC retains all property of DA without being dragged down by its restrictions [@b0615]. A major advantage of DAPC in the Bayesian Cluster approach is the ability to generate graphs that infer kinship between clusters. DAPC can be used to decompose potential structures in more complex demographic models [@b0620].

3.2. Wrapper methods for tumor marker identification from proteomic data {#s0035}
------------------------------------------------------------------------

The wrapper method is one of the most popular feature selection methods proposed by Kohavi and John in 1997 [@b0625]. In the wrapper method, a search for an optimal set of features is made using the induction algorithm as a black box [@b0630]. It provides a simple and powerful technique to solve the challenge of feature selection. The wrapper methods look for the best subset of features based on their predictive power. Wrapper methods are often criticized because they train various new subsets into corresponding models, and need a large amount of computation, but it is not necessarily the case. Researchers can design an effective search strategy. Using this strategy does not necessarily mean sacrificing predictive performance. But it usually provides the best performing feature set for a particular type of model. Generally, different wrapper methods are used to select the best subset. The commonly used methods are Genetic Algorithms (GA), Hill Climbing (HC), Sequential Backward Elimination (SBE), Estimation of Distribution Algorithm (EDA), Simulated Annealing (SA), and Sequential Forward Selection (SFS). Explanation and summary on each wrapper method are provided in [Table 3](#t0015){ref-type="table"}. And the detailed descriptions and the corresponding application of cancer-regulated studies are as follow:Table 3Six wrapper feature selection methods available and popular in cancer proteomic study.MethodAbbr.Packages in R (*Function*)Brief DescriptionReferencesSequential forward selectionSFSDprep (*sffs*)SFS is the only method containing F core steps of linear parameter and is a bottom-up search technique. Many variants and applications are proposed based on SFS.*Pattern recognition and signal processing* 41--60, 1978Sequential backward eliminationSBEMASS (stepAIC)SBE is a linear and parameter algorithm that performs well due to its addressing of large subsets. SBE works in opposite direction.*Pattern recognition and signal processing* 41--60, 1978Simulated annealingSAGenSA (*GenSA*)SSSA is a specific parameters and linear method of approximating the global optimization problems. It is strict with various conditions, but sometimes the cost-increasing can be acceptable.*Soviet Phys Cryst.* 5:905--916, 1979Hill climbingHCFSelector (*hill.climbing.search*)HC is a local search linear and parameter algorithm, which does not need to find the global maximum. Combining with genetic algorithm, HC has been used to predict protein structure.*Proteome Sci.* 1:S19, 2011Genetic algorithmGAGA (ga)GA is an effective and universally applicable function of parameters and linear/unlinear, which does not scale well with complexity.*Mitochondrial DNA* 25:231--7, 2014Estimation of distribution algorithmEDACopulaedas (Copula)EDA is a parameter approach and a widely used random optimization. It belongs to the class of evolutionary algorithms.*IJCSE.* 3:1787--97, 2011

A valid and commonly applicable function minimization method is the Genetic Algorithm (GA) [@b0635]. This method achieves the results of global optimization based on the genetic theory of "survival of the fittest". Unlike traditional search methods, GA begins with a set of finite-length encoded alphabet strings not a real set of parameters [@b0640]. Selection, crossover, and mutation are operators of GA [@b0645]. Through the selection step, a number of individuals which have strong adaptability are found out from the group, and then the individual copy number is determined based on the selection method [@b0650]. Generally speaking, it is necessary to select the suitable crossover and mutation probabilities based on practical problems [@b0655]. GA had been used to maximize functional value in chronic dialysis patients [@b0660]. Moreover, the most famous local search algorithm may be Hill Climbing (HC) [@b0665]. The main idea of climbing is divided into three steps: first, randomly generate a state, and then find the best assessment value to transfer to the neighbor, and finally if the third step has reached a rigid local minimum, restart other randomly created states. These steps need to be repeated until the solution or a local optimum is found [@b0670], [@b0675]. The HC has been applied to predict the protein structure prediction combining with genetic algorithm [@b0680].

The Sequential Backward Elimination (SBE), also called SBS (Sequential Backward Selection), starts from the entire collection, discarding the feature x in turn minimizes the value of the objective function J(Y-x-) [@b0685], [@b0690]. These features are considered non-monotonic. Because SBS is addressing large subsets in most cases, it performs best while the first-rank feature subset exists many features [@b0695]. The primary disadvantage of SBS is that it is not possible to re-evaluate the reusability of this feature when a feature is removed [@b0700]. Sequential Forward Selection (SFS), a bottom-up search technique, works in opposite directions from SBE. SFS is first based on a null feature set and then gradually adds features picked by some assessment functions to minimize Mean Square Error (MSE) [@b0705]. Sharma et al. proposed SFS [@b0710] and attempted to conquer the shortcoming of traditional feature selection method whereby a weakly ranked protein that could conduce to classification accuracy with a suitable subset of proteins has eliminated from the selection [@b0715]. In each iteration, the remaining available features that do not exist in the feature set are selected into the feature set [@b0720]. Therefore, the extended feature set will generate a minimal classification deviation compared to the previously added features [@b0725]. Despite this, SFS is widely applied because of its simplicity and the fact that it only contains F core steps, and many variants and applications are proposed based on the SFS.

Estimation of Distribution Algorithm (EDA), also named Probabilistic Model-building Genetic Algorithm (PMBGA), is a widely used random optimization method [@b0730]. Firstly, EDA learns the explicit probability model which is a promising solution that is currently found, and then generates a new solution by sampling the created model [@b0735]. EDA belongs to a class of evolutionary algorithm. Unlike most traditional evolutionary algorithms which use implicit distributions defined by one or more variant operators to generate new candidate solution, EDA uses Bayesian networks multivariable normal [@b0740]. EDA is an excellent solution to a number of challenging problems [@b0745]. EDA now has been applied to the HP model on a cubic lattice and predict the native structures of relatively small proteins therefore helps in drug design and proteomics [@b0750], [@b0755], [@b0760]. Moreover, the Simulated Annealing (SA) is a specific method for a number of type optimization problems [@b0765]. SA has now been applied to help identify HER2 and hormonal receptor expression states of breast cancer patients [@b0770].

3.3. Embedded methods for tumor marker identification from proteomic data {#s0040}
-------------------------------------------------------------------------

Embedded methods are commonly used in feature selection in order to select the optimal subset of features which play a great role in the process of constructing the classifier [@b0775]. A low minimum sample size of around 20 samples was suggested as sufficient to perform robust power analysis [@b0780]. It is clear that sample imbalance has a great effect on identifying differential features. For example, the imbalance sample in the dataset could lead to model overfitting or underfitting. To deal with the overfitting problem, the dataset could be randomly divided into training (60%), validation (20%), and test (20%) data sets, or training (70%) and test (30%) data sets in case validation is not required [@b0785].

In this section, six methods are listed as follows: Decision Trees (DT), Random Forest (RF), Support Vector Machine (SVM), Bayesian Classifier and Artificial Neural Network (ANN), Random Forest with Recursive Feature Elimination (RF-RFE) and Support Vector Machine with Recursive Feature Elimination (SVM-RFE) [@b0420]. Explanation on each method is provided in [Table 4](#t0020){ref-type="table"}, and detailed descriptions and the corresponding application of cancer-regulated studies are as follow:Table 4Seven embedded feature selection methods available and popular in cancer proteomic study.MethodsAbbr.Packages in R (*Function*)Brief DescriptionsReferenceDecision TreeDTdtree (*pca*)The DT is a supervised algorithm for classification and prediction. And it is suitable for nonlinear proteomic data.*Machine Learning.* 4:161--86, 1989Support Vector MachineSVM*e1071* (*svm*)The SVM is a supervised learning model for classification and regression. And it is suitable any linear or nonlinear proteomic data, but also complex and time consuming for large scale proteomic data.*Bioinformatics.* 21:47--56, 2005Weighted naïve BayesWNBCORElearn (*CoreModel*)The WNB is a supervised learning method based on the Bayes theory. And it is only suitable for the proteomic data, where all variables are independent of each other.*Appl Environ Microbiol.* 73:5261--7, 2007SVM Recursive Feature EliminationSVM-RFEMCRestimate (*varSel.svm.rfe*)The SVM-RFE is popular supervised embedded method. And it is well suitable for addressing overfitting risk when the number of variables is high.*Anal Chem.* 80: 7562--70, 2008Artificial Neural NetworksANN*neuralnet* (*neuralnet*)The ANN is supervised embedded method. And its performance on consistent depended on the characteristic of studied data.*Nat Rev Urol.* 10:174--82, 2013Random ForestRFrandomForest (*randomFores*)The RF is popular supervised embedded method. And it is well suitable for any proteomic dataset for identifying the small variables set.*Isprs Journal of Photogrammetry & Remote Sensing.* 67:93--104, 2012RF Recursive Feature EliminationRF-RFEvarSelRF (*varSelRF*)The RF-RFE is popular supervised embedded method. And it is well suitable for addressing the non-linear or linear variables of proteomic dataset.Metabolomics. 18: 3677--85, 2012

Decision Tree learner is a common decision support tool that resembles a tree structure in which each non-leaf node represents a test on a specific characteristic, each branch means the result of the test, and each leaf node denotes a class label [@b0790]. Through an iterative process, the Decision Tree learns from a series of training examples, selects an attribute and then splits a given set of examples based on the values of that attribute [@b0795]. Advantages of the method can be summed up in two aspects. First, the construction of the classifier does not require much of professional knowledge and its reliability in diagnosis can be verified through both expert knowledge and testing data [@b0800]. Besides, its inductive classification step is simple and fast [@b0795].

Random Forest developed by Leo Breiman is an algorithm that integrates multiple trees through the idea of integrated learning [@b0805]. Its basic unit is Decision Tree which takes the advantage of a bootstrap sample of the data [@b0810]. The method is excellent in accuracy [@b0815] and generates an internal unbiased estimate of the generalization error as the forest building progresses. Moreover, when comparing with SVM, it performs better in the aspect of classification tasks [@b0820]. Random Forest with Recursive Feature Elimination (RF-RFE) conducts a recursive backward feature elimination procedure. It begins with all the features. In each iteration, a Random Forest is constructed to measure the features' importance and the feature with least importance is removed. This procedure is repeated until there is no feature left. Finally, the features are ranked according to the deleted sequence, and the top ranked feature is the last deleted one. RF-RFE has been applied to reveal the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver [@b0825], [@b0830], and investigate hepatitis C by using metabolomics as a tool [@b0315].

Support Vector Machine (SVM) is a kind of learning machines constructed according to structural risk minimization principle on the basis of Vector Machine theory, which hopes to find a segmentation surface that can separate the data points apart [@b0835]. One of the challenges of this method is how to choose the proper kernel function [@b0840]. When it comes to the advantages of SVM, it performs well in dealing with high-dimensional data sets with very few training examples [@b0845]. Moreover, as family of simple "probabilistic classifiers" based on Bayes theory, the Bayesian Classifier can be applied to predict the probability that a given instance pertains to a class [@b0850]. It assumes that all the attributes are independent of each other [@b0855]. In theory, the naive Bayesian classifier has the minimum error rate when compared to other classification methods. However, this is not always the case in practice due to the above assumption. Even so, the Naive Bayesian classifier has the high precision and speed in the application of large database [@b0860].

Support Vector Machine with Recursive Feature Elimination (SVM-RFE) is an embedded approach that uses the norm of the weights w to rank the variables. Initially, all data is taken, and a classifier is computed. The norm of w is then computed for each of the features and the feature with the smallest norm is eliminated. This process is repeated until all features are ranked. For selecting features relevant to the spiked compounds, linear SVM-RFE performs poorly even if the classification error is relatively low [@b0080]. SVM-RFE has been applied to determine differences between healthy subjects and patients suffering from Streptococcus pneumoniae [@b0865], and interrogate the serum metabolome of early-stage ovarian cancer patients and age-matched control women [@b0870].

Artificial Neural Networks (ANN) is an algorithm mathematical that simulates the behavior characteristics of biological neural networks, including their structure and functionalities [@b0875]. The basic unit of every artificial neural network is artificial neuron which is a simple mathematical function [@b0880]. This kind of network relies on the complexity of the system and can process information by adjusting the weight of the interconnection between a large number of nodes (neurons) within the system [@b0885]. Requiring less formal statistical training, ANN performs well in detecting the complex non-linear relationship between dependent and independent variables [@b0890].

In addition to the above feature selection methods, deep learning is also a type of machine learning approaches which enables to identify the highly complex patterns in omics data [@b0895], [@b0900], [@b0905]. Common deep learning methods included the convolutional neural networks, recurrent neural networks and deep neural networks [@b0910]. Untill now, deep learning has been widely applied in cancer proteomics [@b0915]. For example, the deep learning approach has been applied for the diagnosis of pancreatic cancer in proteomic data [@b0915].

4. Sample clustering and visualization {#s0045}
======================================

Clustering or unsupervised modeling is a powerful technique for discovering the molecular classification of patient's cancer tissues [@b0920] and identifying subtype specific characterization (e.g. subtype specific cancer therapeutic targets) [@b0925], [@b0930]. The underlying theories of clustering technique are considering the similarities among different samples based on high dimension proteins or peptides, which can provide information of the same or differential patterns on protein expression level, aiming at clustering those biologically similar samples together [@b0935]. Therefore, the unsupervised approaches are widely applied to characterize and analyze the complex proteomic dataset. Currently, there are five different approaches for sample separation of cancer proteomic dataset, including three clustering methods and two popular reducing dimension methods [@b0940]. In cluster analysis, Hierarchical Cluster Analysis (HCA), Self-organizing Map (SOM) and K-means Clustering are three prominent representatives in the analysis of proteomic data [@b0945]. Principal Component Analysis (PCA) and the state of art stochastic neighbor embedding analysis based on Student t Distribution (t-SNE) [@b0950], [@b0920] are the most commonly used unsupervised approaches of reduction dimensions in cancer proteomic studies [@b0940]. Explanation on these methods is provided in [Table 5](#t0025){ref-type="table"}. Detailed descriptions and the corresponding application of cancer-regulated studies are as follow.Table 5Five methods for sample clustering and dimension reduction available in cancer proteomics.MethodsAbbr.Packages in R (*Function*)Brief DescriptionsReferencePrincipal Component AnalysisPCAropls (*pca*)The PCA is unsupervised, non-parametric and linear method of reduce dimension method. And Unsuitable the dataset when the proteins or peptides were nonlinear relationship.*Clin Biochem.* 56:55--61, 2016t-Distributed Stochastic Neighbor Embeddingt-SNERtsne (*Rtsne*)The t-SNE is unsupervised, non-parametric and non-linear method of reduce dimension method. And Unsuitable the dataset when the proteins or peptides were linear relationship.*J Mach Learn Res*. 9:25S79--605, 2008Self-Organizing MapSOMSom (*som*)The SOM is unsupervised, non-parametric and non-linear method of clustering. And suitable for any proteomic the dataset.*IEEE Trans Neural Netw*. 11(3):574--85, 2000Hierarchical Cluster AnalysisHCACluster (*agnes*)The HCA is unsupervised, non-parametric and non-linear method of clustering. And suitable the any datasets.*Front Bioeng Biotechnols*. 3:23. 2015K-Means ClusteringK-Meansskmeans (*skmeans*)The K-Means is unsupervised, non-parametric and non-linear method of clustering. And Unsuitable the dataset when the number of clusters is not known.*Proteomics.* 16:1613--21, 2016

The Principal Component Analysis (PCA) aims at interpreting the first few principal components that often explain thousands of the variables, and is often applied strategy of reducing dimension for high dimensional cancer proteomic data [@b0955]. Particularly, a multivariate proteomic dataset can first be transformed based on the linear relationship between different proteins or peptides [@b0940], and then determine the most significant Principal Components (PCs) according to the obtained variances [@b0955]. In PCA analysis, the scatterplots (e.g. scores plot and loadings plot) are often used for visualizing correlation of the biological samples or the importance of proteins/peptides to discriminate those differential samples, which are often visualized based on two axes (two principal components) or three axes (three principal components). The PCA scores plot demonstrates the discriminative power between different sample groups (these points represent the corresponding samples). The PCA scores plots establish whether there are any intrinsic differences in the composition of samples. Moreover, the loading plots of proteome from PCA models display proteins or peptides positively correlated with score plots. From the loading plots, differential proteins or peptides between control and cancer subjects are identified [@b0960]. In general, the more these variables are away from center points, the more significant differences they can be considered. The PCA has been widely applied in comparative proteomic analysis, for example liver cirrhosis and gastric cancer samples clustering and visualization [@b0965]. The PCA has been also applied in metabolomics to produce global metabolite profiles by studying perturbations under different biological [@b0970] and studying toxicity induced by drugs [@b0975].

Compared with the principal component analysis, the Stochastic Neighbor Embedding (SNE) method is a recently proposed and much more effective on-linear dimensionality algorithm of reducing dimension, which visualizes high-dimensional data by describing the similarity of samples using a low dimension space. The technique is primarily derived from SNE [@b0980], and has unique advantages of using symmetrized SNE with straightforward gradients and computing the similarity between two samples based t distribution. Thus, SNE can alleviate crowded area of the two or three-dimensional map, and be quite suitable for exploring the optimal global organizations of the data based on the early exaggeration trick. SNE map is widely applied for cancer proteomic studies, for example, uncovering subtypes of gastric cancer and metastasis status in primary breast cancer [@b0985].

When the number of clusters is unknown, the most prevalent clustering techniques would be unsupervised Hierarchical Clustering Analysis (HCA). The HCA can perform the clustering of samples by a dendrogram or tree plot [@b0990]. The proteins expression levels or the studied samples can be clustered in a dendrogram [@b0995]. The correlation coefficient across samples can be estimated based on the specific distance (e.g. Euclidean, Manhattan or Maximum distances). For these samples with the highest correlation coefficients, they would be categorized into the same cluster. The obtained dendrograms can explain many biological issues in the context of cancer subtypes and development statuses [@b1000]. HCA is widely applied for cancer proteomic studies to identify the co-expression patterns of differentially expressed proteins in hepatocellular carcinoma based on iTRAQ quantitative proteomics analysis [@b1005].

The K-means Clustering is prevalently used in cancer proteomic data when the number of underlying clusters is known [@b1010]. The K-means Clustering aims at performing the grouping based on the known the clusters number k, and categorizing n samples into the k classes [@b1015]. These samples with the most similarity values can be considered the same class, and the similarities are computed using Euclidean Distances. Compared with the HCA, the method often needs additional check procedures to identify the optimal clusters number. The method has been widely applied for identifying the co-expression patterns in glioblastoma multiform based the protein expression level [@b1020]. Self-organizing Map analysis (SOM) is another popular clustering method applied in cancer proteomic study, which aims at describing the similarity of studied samples based on low dimensional map space [@b1025]. The advantages of SOM are that it doesn't need to input the known cluster number and these similarity samples exist topological relationships. In summary, SOM regards the most similarity samples as in a clustering. Thus, SOM provides a map, in which, similar samples are grouped together, and disparate samples can be separated into different groups. SOM has been widely applied in multiple omics study to visualize samples phenotypes as well as variables patterns [@b0940], for example, revealing unique dynamic expression patterns of proteins among the different colorectal cancer status [@b0995]. SOM has also been applied to metabolic study for visualization of differential metabolites associated with wound response of *Arabidopsis thaliana* [@b1030].

5. Conclusions {#s0050}
==============

Tumor marker selection and sample classification are key issues in current cancer proteomics study. The biomarker sets identified via feature selection methods were inconsistency in several publications. This article reviewed the popular feature selection methods currently applied in tumor maker selection and discussed several sample classification algorithms available for cancer proteomic. These advances made the MS-based proteomics technology more widely applied to identify diagnostic, prognostic, and therapeutic biomarkers for anticancer drug discovery. Moreover, the pathogenetic process of a specific disease could be comprehensively and better understood using a panel of biomarkers, under this circumstance, the wrapper and embedded feature selection methods were suitable for selecting a small the feature panel in the tumor marker identifications.
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